COMPANY

Cartography Biosciences

Keywords: oncology immunology cancer antibody Colorectal Cancer Colorectal (Colon or Rectal) Cancer CRC Metastatic Colon Cancer Colon Cancer Advanced Colorectal Cancer CBI-1214

Profile checked Oct 10, 2026

1Trials (company is sponsor)

Timeline

Jan 15, 2026 Trial start Phase 1: A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer source ↗

Upcoming milestones

2029-04 (ESTIMATED) · Phase 1 · A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer · NCT07321106

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 1

Record	Title	Phase	Status	Start	Primary completion
NCT07321106	A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer	Phase 1	Recruiting	Jan 15, 2026	2029-04 (estimated)